If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.

A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States Food and Drug ...

The government program, known as 340B, allows hospitals that care for many uninsured and low-income patients to purchase ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity ...

This story mentions weight, weight loss, and/or GLP-1 drugs. In the last few years, GLP-1s, prescription weight loss medications for people who are obese or who are overweight and have one ...

Phil Stevens, from Hampshire, said he developed an addiction to gambling and spending after taking prescription medication ...

Women who were prescribed medication to deal with a neurological disorder that impacts one in 10 Americans have said that the ...

Prevalence rates of what GSK calls "deviant" sexual behaviours caused by the drugs are unknown and tend to be under-reported ...

The U.S. over the counter (OTC) drugs market was valued at US$ 41.93 billion in 2024 and is projected to reach a market valuation of US$ 69.65 billion by 2033, growing at a CAGR of 5.8% during the ...

The pharma industry registered a 7.5% value growth year-on-year for the month of February, with sales of ₹18,781 crore, ...

Bio­haven’s potas­si­um chan­nel drug has failed a late-stage study in bipo­lar ma­nia, ac­cord­ing to a state­ment in the com­pa­ny’s fourth-quar­ter earn­ings re­port.

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...